Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$132.59
+0.9%
$130.99
$110.86
$141.23
$230.89B0.75.40 million shs4.43 million shs
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$455.58
-0.1%
$446.99
$410.11
$618.95
$106.37B0.271.53 million shs1.37 million shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%+0.13%+5.09%-0.82%+17.43%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
0.00%+2.21%+8.18%-5.34%-19.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.8808 of 5 stars
2.54.04.24.52.52.52.5
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
4.4106 of 5 stars
3.23.04.20.01.61.72.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.91
Moderate Buy$144.478.97% Upside
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
2.38
Hold$506.3511.14% Upside

Current Analyst Ratings Breakdown

Latest ABT and LMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/28/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Alembic Global Advisors
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Overweight
8/21/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$495.00 ➝ $480.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$498.00 ➝ $453.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$520.00 ➝ $465.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Susquehanna
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetPositive ➝ Positive$550.00 ➝ $490.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$480.00 ➝ $440.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$540.00 ➝ $500.00
7/23/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$554.00 ➝ $440.00
7/22/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$460.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$147.00 ➝ $142.00
7/18/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$142.00 ➝ $141.00
(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.50$6.58 per share20.15$29.20 per share4.54
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$71.04B1.50$35.54 per share12.82$22.85 per share19.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.9816.6123.142.5232.43%18.32%10.71%10/15/2025 (Estimated)
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$5.34B$17.7625.6515.341.605.85%107.60%12.13%10/28/2025 (Estimated)

Latest ABT and LMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/22/2025Q2 2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$6.57$7.29+$0.72$1.46$18.59 billion$18.16 billion
7/17/2025Q2 2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.26$1.26N/A$1.01$11.01 billion$11.14 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.78%N/A29.57%54 Years
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
$13.202.90%N/A74.32%22 Years

Latest ABT and LMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
quarterly$3.302.88%9/2/20259/2/20259/26/2025
6/13/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.73%7/15/20257/15/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.25
1.82
1.30
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
3.47
0.98
0.83

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
74.19%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
0.14%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.73 billionOptionable
Lockheed Martin Corporation stock logo
LMT
Lockheed Martin
121,000233.46 million233.14 millionOptionable

Recent News About These Companies

Avenir Corp Boosts Stake in Lockheed Martin Corporation $LMT

New MarketBeat Followers Over Time

Media Sentiment Over Time

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$132.59 +1.22 (+0.93%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$132.50 -0.09 (-0.07%)
As of 08/29/2025 07:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Lockheed Martin stock logo

Lockheed Martin NYSE:LMT

$455.58 -0.60 (-0.13%)
Closing price 08/29/2025 03:59 PM Eastern
Extended Trading
$455.19 -0.39 (-0.09%)
As of 08/29/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lockheed Martin Corporation, a security and aerospace company, engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services worldwide. The company operates through Aeronautics, Missiles and Fire Control, Rotary and Mission Systems, and Space segments. The Aeronautics segment offers combat and air mobility aircraft, unmanned air vehicles, and related technologies. The Missiles and Fire Control segment provides air and missile defense systems; tactical missiles and air-to-ground precision strike weapon systems; logistics; fire control systems; mission operations support, readiness, engineering support, and integration services; manned and unmanned ground vehicles; and energy management solutions. The Rotary and Mission Systems segment offers military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment offers satellites; space transportation systems; strategic, advanced strike, and defensive systems; and classified systems and services in support of national security systems. This segment also provides network-enabled situational awareness and integrates space and ground global systems to help its customers gather, analyze, and securely distribute critical intelligence data. It serves primarily serves the U.S. government, as well as foreign military sales contracted through the U.S. government. The company was founded in 1912 and is based in Bethesda, Maryland.